tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ABOS Stock Latest News

Acumen Pharmaceuticals Advances Alzheimer’s Therapeutic
Company AnnouncementsAcumen Pharmaceuticals Advances Alzheimer’s Therapeutic
1M ago
ABOS
Acumen Pharma Reports Q3 2024, Highlights Alzheimer’s Focus
PremiumCompany Announcements
Acumen Pharma Reports Q3 2024, Highlights Alzheimer’s Focus
1M ago
8K
ABOS
Acumen reports Q3 EPS (50c), consensus (36c)
PremiumThe Fly
Acumen reports Q3 EPS (50c), consensus (36c)
1M ago
ABOS
ABOS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ABOS Earnings this Week: How Will it Perform?
1M ago
ABOS
Acumen appoints Schacterle as Chief Regulatory Officer, Head of Quality
PremiumThe Fly
Acumen appoints Schacterle as Chief Regulatory Officer, Head of Quality
1M ago
ABOS
SAGE
Acumen presents data on pTau217 assay to screen for Phase 2 ALTITUDE-AD trial
PremiumThe FlyAcumen presents data on pTau217 assay to screen for Phase 2 ALTITUDE-AD trial
2M ago
ABOS
Acumen to deliver late-breaking presentation on ACU193 at CTAD conference
Premium
The Fly
Acumen to deliver late-breaking presentation on ACU193 at CTAD conference
2M ago
ABOS
Acumen extends collaboration with Lonza
Premium
The Fly
Acumen extends collaboration with Lonza
3M ago
ABOS
Acumen Pharmaceuticals Unveils Updated Corporate Presentation and Financials
PremiumCompany Announcements
Acumen Pharmaceuticals Unveils Updated Corporate Presentation and Financials
4M ago
8K
ABOS
Acumen reports Q2 EPS (34c), consensus (28c)
PremiumThe Fly
Acumen reports Q2 EPS (34c), consensus (28c)
4M ago
ABOS
Acumen Pharmaceuticals, Inc. (ABOS) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Acumen Pharmaceuticals, Inc. (ABOS) Q2 Earnings Cheat Sheet
4M ago
ABOS
Acumen announces first subject dosed in Phase 1 study of sabirnetug
PremiumThe Fly
Acumen announces first subject dosed in Phase 1 study of sabirnetug
5M ago
ABOS
Acumen presents patient experience, biomarker Data from Phase 1 INTERCEPT-AD
PremiumThe FlyAcumen presents patient experience, biomarker Data from Phase 1 INTERCEPT-AD
5M ago
ABOS
Acumen initiated with a Buy at Citi
Premium
The Fly
Acumen initiated with a Buy at Citi
5M ago
ABOS
Acumen will present patient experience, data from Phase 1 INTERCEPT-AD study
Premium
The Fly
Acumen will present patient experience, data from Phase 1 INTERCEPT-AD study
5M ago
ABOS
Acumen Pharmaceuticals Begins Phase 2 Trial and Updates Finances
PremiumCompany Announcements
Acumen Pharmaceuticals Begins Phase 2 Trial and Updates Finances
7M ago
8K
ABOS
Acumen sees cash runway into 1H27
PremiumThe Fly
Acumen sees cash runway into 1H27
7M ago
ABOS
Acumen reports Q1 EPS (25c), consensus (26c)
PremiumThe Fly
Acumen reports Q1 EPS (25c), consensus (26c)
7M ago
ABOS
Acumen announces first patient dosed in ALTITUDE-AD study
PremiumThe Fly
Acumen announces first patient dosed in ALTITUDE-AD study
8M ago
ABOS
These 2 ‘Strong Buy’ Penny Stocks Are Poised for Over 300% Gains, Say Analysts
PremiumStock Analysis & IdeasThese 2 ‘Strong Buy’ Penny Stocks Are Poised for Over 300% Gains, Say Analysts
8M ago
ABOS
ELDN
Acumen presents first clinical, biomarker data for ACU193
Premium
The Fly
Acumen presents first clinical, biomarker data for ACU193
8M ago
ABOS
Acumen teams with Lonza for advancement of sabirnetug to treat AD
Premium
The Fly
Acumen teams with Lonza for advancement of sabirnetug to treat AD
9M ago
ABOS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >